The effects of an innovative GP-physiotherapist partnership in improving COPD management in primary care.
Allied health
COPD
Physical activity
Primary care
Pulmonary rehabilitation
Journal
BMC primary care
ISSN: 2731-4553
Titre abrégé: BMC Prim Care
Pays: England
ID NLM: 9918300889006676
Informations de publication
Date de publication:
10 07 2023
10 07 2023
Historique:
received:
06
09
2022
accepted:
29
06
2023
medline:
12
7
2023
pubmed:
11
7
2023
entrez:
10
7
2023
Statut:
epublish
Résumé
Evidence suggests that management of people with Chronic Obstructive Pulmonary Disease (COPD) in primary care has been suboptimal, in particular, with low referral rates to pulmonary rehabilitation (PR). The aim of this study was to evaluate the effectiveness of a GP-physiotherapist partnership in optimising management of COPD in primary care. A pragmatic, pilot, before and after study was conducted in four general practices in Australia. A senior cardiorespiratory physiotherapist was partnered with each general practice. Adults with a history of smoking and/or COPD, aged ≥ 40 years with ≥ 2 practice visits in the previous year were recruited following spirometric confirmation of COPD. Intervention was provided by the physiotherapist at the general practice and included PR referral, physical activity and smoking cessation advice, provision of a pedometer and review of inhaler technique. Intervention occurred at baseline, one month and three months. Main outcomes included PR referral and attendance. Secondary clinical outcomes included changes in COPD Assessment Test (CAT) score, dyspnoea, health activation and pedometer step count. Process outcomes included count of initiation of smoking cessation interventions and review of inhaler technique. A total of 148 participants attended a baseline appointment where pre/post bronchodilator spirometry was performed. 31 participants with airflow obstruction on post-bronchodilator spirometry (mean age 75yrs (SD 9.3), mean FEV The results of this study suggest that this model was able to increase referrals to PR from primary care and was successful in implementing some aspects of COPD management, however, was insufficient to improve symptom scores and physical activity levels in people with COPD. ANZCTR, ACTRN12619001127190. Registered 12 August 2019 - Retrospectively registered, http://www.ANZCTR.org.au/ACTRN12619001127190.aspx .
Sections du résumé
BACKGROUND
Evidence suggests that management of people with Chronic Obstructive Pulmonary Disease (COPD) in primary care has been suboptimal, in particular, with low referral rates to pulmonary rehabilitation (PR). The aim of this study was to evaluate the effectiveness of a GP-physiotherapist partnership in optimising management of COPD in primary care.
METHODS
A pragmatic, pilot, before and after study was conducted in four general practices in Australia. A senior cardiorespiratory physiotherapist was partnered with each general practice. Adults with a history of smoking and/or COPD, aged ≥ 40 years with ≥ 2 practice visits in the previous year were recruited following spirometric confirmation of COPD. Intervention was provided by the physiotherapist at the general practice and included PR referral, physical activity and smoking cessation advice, provision of a pedometer and review of inhaler technique. Intervention occurred at baseline, one month and three months. Main outcomes included PR referral and attendance. Secondary clinical outcomes included changes in COPD Assessment Test (CAT) score, dyspnoea, health activation and pedometer step count. Process outcomes included count of initiation of smoking cessation interventions and review of inhaler technique.
RESULTS
A total of 148 participants attended a baseline appointment where pre/post bronchodilator spirometry was performed. 31 participants with airflow obstruction on post-bronchodilator spirometry (mean age 75yrs (SD 9.3), mean FEV
CONCLUSION
The results of this study suggest that this model was able to increase referrals to PR from primary care and was successful in implementing some aspects of COPD management, however, was insufficient to improve symptom scores and physical activity levels in people with COPD.
TRIAL REGISTRATION
ANZCTR, ACTRN12619001127190. Registered 12 August 2019 - Retrospectively registered, http://www.ANZCTR.org.au/ACTRN12619001127190.aspx .
Identifiants
pubmed: 37430190
doi: 10.1186/s12875-023-02097-3
pii: 10.1186/s12875-023-02097-3
pmc: PMC10332030
doi:
Substances chimiques
Bronchodilator Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
142Informations de copyright
© 2023. The Author(s).
Références
Eur Respir J. 2009 Feb;33(2):262-72
pubmed: 19010994
Med Care Res Rev. 2009 Feb;66(1 Suppl):9S-27S
pubmed: 19052169
Health Aff (Millwood). 2013 Feb;32(2):207-14
pubmed: 23381511
Am J Respir Crit Care Med. 2015 Aug 1;192(3):295-306
pubmed: 26020495
Cochrane Database Syst Rev. 2017 Aug 04;8:CD011682
pubmed: 28777450
Chest. 1988 Mar;93(3):580-6
pubmed: 3342669
Eur Respir Rev. 2013 Mar 1;22(127):37-43
pubmed: 23457163
Am J Health Promot. 1997 Sep-Oct;12(1):38-48
pubmed: 10170434
Respirology. 2005 Jun;10(3):334-40
pubmed: 15955146
Eur Respir J. 2008 Oct;32(4):844-53
pubmed: 18827152
Health Psychol. 1992;11(6):386-95
pubmed: 1286658
Med J Aust. 2022 Oct 17;217(8):415-423
pubmed: 36116098
Chest. 2002 May;121(5):1441-8
pubmed: 12006426
Respir Med. 2018 Apr;137:103-114
pubmed: 29605192
Cochrane Database Syst Rev. 2016 Dec 08;12:CD005305
pubmed: 27930803
BMJ. 2014 Sep 10;349:g5392
pubmed: 25209620
Lancet Respir Med. 2014 Mar;2(3):195-203
pubmed: 24621681
Health Serv Res. 2004 Aug;39(4 Pt 1):1005-26
pubmed: 15230939
Eur Respir J. 2014 Dec;44(6):1521-37
pubmed: 25359358
Fam Pract. 2016 Dec;33(6):663-670
pubmed: 27535327
Cochrane Database Syst Rev. 2020 Apr 16;4:CD012626
pubmed: 32297320
Eur Respir J. 2005 Aug;26(2):234-41
pubmed: 16055870
Respir Med. 2012 Mar;106(3):374-81
pubmed: 22000501
Cochrane Database Syst Rev. 2015 Feb 23;(2):CD003793
pubmed: 25705944
Int J Chron Obstruct Pulmon Dis. 2016 Aug 17;11:1929-37
pubmed: 27574417
ERJ Open Res. 2020 Feb 17;6(1):
pubmed: 32083112
Int J Chron Obstruct Pulmon Dis. 2011;6:171-9
pubmed: 21468169
Physiother Can. 2010 Fall;62(4):368-73
pubmed: 21886377
Cochrane Database Syst Rev. 2013 Oct 10;(10):CD009437
pubmed: 24108523
MedGenMed. 2007 Jul 31;9(3):24
pubmed: 18092030
Eur Respir J. 2019 Apr 25;53(4):
pubmed: 30792342
Pilot Feasibility Stud. 2020 Sep 23;6:138
pubmed: 32983555
Health Serv Res. 2005 Dec;40(6 Pt 1):1918-30
pubmed: 16336556
Am J Respir Crit Care Med. 2013 Oct 15;188(8):e13-64
pubmed: 24127811
PLoS One. 2016 Apr 28;11(4):e0154587
pubmed: 27124297
Chron Respir Dis. 2011;8(2):89-99
pubmed: 21596892
Respir Res. 2011 Mar 22;12:33
pubmed: 21426563
Respirology. 2017 May;22(4):800-819
pubmed: 28339144
Eur Respir J. 2018 May 10;51(5):
pubmed: 29650559
Eur Respir J. 2009 Sep;34(3):648-54
pubmed: 19720809
J Physiother. 2017 Apr;63(2):84-93
pubmed: 28433238
Int J Chron Obstruct Pulmon Dis. 2011;6:659-67
pubmed: 22259242
Aust Fam Physician. 2009 Oct;38(10):826-30
pubmed: 19893824
Scand J Prim Health Care. 2016;34(1):55-65
pubmed: 26849465
BMC Pulm Med. 2008 Jun 03;8:8
pubmed: 18519003